Test | Description | Normal Results | Comments | ||
---|---|---|---|---|---|
Complete blood count | Peripheral whole-blood sample for hemoglobin, hematocrit, and platelets | Age | Values in Males (g/dL) | Values in Females (g/dL) | Requirement for transfusion is based on a patient's underlying illness and overall clinical presentation. Ranges may vary by institution or laboratory. |
Newborn | 13–22 | 13–22 | |||
1–24 Months | 9.5–14 | 9.5–14 | |||
2–10 Years | 11.5–14.5 | 11.5–14.5 | |||
10–17 Years | 12.5–16.1 | 12–15 | |||
Adults | 13.5–18 | 12.5–16 | |||
Hemoglobin: | |||||
Age | Values in Males (%) | Values in Females (%) | |||
Newborn | 45–67 | 45–67 | |||
1–2 Months | 31–55 | 31–55 | |||
2–3 Months | 28–42 | 28–42 | |||
3–6 Months | 29–41 | 29–41 | |||
6–24 Months | 33–39 | 33–39 | |||
2–10 Years | 34–45 | 34–45 | |||
10–17 Years | 37–49 | 37–49 | |||
Adult | 41–53 | 36–46 | |||
Hematocrit: | |||||
Age | Values in Males (g/dL) | Values in Females (g/dL) | |||
Newborn to adult | 140–450 × 109/L | 140–450 × 109/L | |||
Platelets: | |||||
Chemistry profile | Age (Years) | Values in Males (U/L) | Values in Females (U/L) | Elevated liver enzymes may indicate underlying liver disease. | |
0–5 | 35–140 | 20–93 | |||
6–3 | 20–60 | 20–93 | |||
4–6 | 15–50 | 16–61 | |||
7–9 | 14–40 | 15–40 | |||
10–11 | 10–60 | 10–40 | |||
12–15 | 15–40 | 5–30 | |||
Aspartate transaminase: | |||||
Age | Values in Males (U/L) | Values in Females (U/L) | |||
1–7 Days | 20–54 | 21–54 | |||
8–30 Days | 24–54 | 22–46 | |||
1–3 Months | 27–54 | 26–61 | |||
4–6 Months | 27–54 | 26–61 | |||
7–12 Months | 26–59 | 26–55 | |||
1–3 Years | 19–59 | 24–59 | |||
4–6 Years | 24–49 | 24–49 | |||
10–11 Years | 24–49 | 24–44 | |||
12–13 Years | 24–68 | 24–44 | |||
14–15 Years | 24–59 | 19–44 | |||
16–19 Years | 24–54 | 19–49 | |||
Alanine aminotransferase: | |||||
Age | Values in Males (U/L) | Values in Females (U/L) | |||
1–30 Days | 16–450 | 16–450 | |||
1–3 Months | 16–267 | 16–267 | |||
3–5 Months | 16–167 | 16–167 | |||
5–8 Months | 8–84 | 8–84 | |||
9 Months to 17 years | 5–55 | 5–55 | |||
>17 Years | 15–85 | 5–55 | |||
γ-Glutamyl-transferase: | |||||
Age | Values in Males (mg/dL) | Values in Females (mg/dL) | |||
1 Month to adult | 0.2–1.2 | 0.2–1.2 | |||
Total bilirubin: | |||||
Age | Values in Males (mg/dL) | Values in Females (mg/dL) | A BUN-to-creatinine ratio >30 has excellent specificity (98%) and good sensitivity (68.8%) for UGIB. | ||
0–3 Days | 0.2–1 | 0.2–1 | |||
4 Days to 2 years | 0.2–0.5 | 0.2–0.6 | |||
2–4 Years | 0.3–0.6 | 0.2–0.7 | |||
5–7 Years | 0.2–0.7 | 0.2–0.8 | |||
8–10 Years | 0.3–0.8 | 0.3–0.9 | |||
11–12 Years | 0.3–0.9 | 0.3–1 | |||
13–17 Years | 0.3–1.1 | 0.3–1.2 | |||
>17 Years | 0.3–1.1 | 0.5–1.3 | |||
Creatinine: | |||||
Age | Values in Males (mg/dL) | Values in Females (mg/dL) | |||
0 Days to adult | 6–17 | 6–17 | |||
BUN: | |||||
Coagulation studies | Venous sample from citrated tube for PT/INR, PTT | PT: 11–15 sec INR: 1 PTT: 25–35 sec | Prolonged PT/INR or PTT may indicate preexisting coagulopathy, liver dysfunction, or acute illness such as sepsis or disseminated intravascular coagulation. |
BUN, blood urea nitrogen; INR, international normalized ratio; PT, prothrombin time; PTT, partial thromboplastin time; UGIB, upper gastrointestinal bleeding.